NEVVI Medicare utilization intelligence
or

← back

Provider profile

SYED, NAYYAR MD

Medical Oncology · NPI 1154411635 · PITTSBURG, TX

1
Groups
45
Codes · 2024
139,822
Disclosed services

SYED, NAYYAR is a Medical Oncology in PITTSBURG, TX, a member of 1 medical group, who billed 45 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

139,822
disclosed services
45
codes billed to Medicare Part B
Prior year · CY2023 154,519 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96375 Injection of additional new drug or substance into vein
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82728 Ferritin (blood protein) level
83540 Iron level
96413 Administration of chemotherapy into vein, 1 hour or less
83550 Iron binding capacity
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85055 Reticulated (young) platelet measurement
J1200 Injection, diphenhydramine hcl, up to 50 mg
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99195 Drawing of blood for a medical problem
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
96374 Injection of drug or substance into vein
96523 Irrigation of implanted venous access drug delivery device
83735 Magnesium level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.